Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascual Sanz

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Neuroreport|February 10, 2017
4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora diseaseGentzane Sánchez-Elexpuru, José M Serratosa, Pascual Sanz, et al.
Neurobiology of Disease|December 16, 2022
TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsyTeresa Rubio, Rosa Viana, Mireia Moreno-Estellés, et al.
Journal of Human Genetics|March 7, 2008
Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patientsItziar Estalella, Maria Adelaida Garcia-Gimeno, Alberto Marina, et al.
Cellular Signalling|April 21, 2006
TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinaseM Carmen Solaz-Fuster, José Vicente Gimeno-Alcañiz, Marta Casado, et al.
Molecular Biology of the Cell|June 11, 2010
The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunitsDaniel Moreno, Mhairi C Towler, D Grahame Hardie, et al.
Plos One|June 17, 2009
Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforinSantiago Vernia, Teresa Rubio, Miguel Heredia, et al.
Biochemical and Biophysical Research Communications|March 11, 2008
Role of AMP-activated protein kinase in autophagy and proteasome functionRosa Viana, Carmen Aguado, Inmaculada Esteban, et al.
The Biochemical Journal|July 1, 2008
Human pancreatic beta-cell glucokinase: subcellular localization and glucose repression signalling function in the yeast cellAlberto Riera, Deifilia Ahuatzi, Pilar Herrero, et al.
Cells|April 30, 2021
TRIM32 and Malin in Neurological and Neuromuscular Rare DiseasesLorena Kumarasinghe, Lu Xiong, Maria Adelaida Garcia-Gimeno, et al.
FEBS Letters|November 3, 2012
Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathwayLuisa Garcia-Haro, Maria Adelaida Garcia-Gimeno, Dietbert Neumann, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Neuroreport|February 10, 2017
4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora diseaseGentzane Sánchez-Elexpuru, José M Serratosa, Pascual Sanz, et al.
Neurobiology of Disease|December 16, 2022
TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsyTeresa Rubio, Rosa Viana, Mireia Moreno-Estellés, et al.
Journal of Human Genetics|March 7, 2008
Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patientsItziar Estalella, Maria Adelaida Garcia-Gimeno, Alberto Marina, et al.
Cellular Signalling|April 21, 2006
TRIP6 transcriptional co-activator is a novel substrate of AMP-activated protein kinaseM Carmen Solaz-Fuster, José Vicente Gimeno-Alcañiz, Marta Casado, et al.
Molecular Biology of the Cell|June 11, 2010
The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunitsDaniel Moreno, Mhairi C Towler, D Grahame Hardie, et al.
Plos One|June 17, 2009
Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforinSantiago Vernia, Teresa Rubio, Miguel Heredia, et al.
Biochemical and Biophysical Research Communications|March 11, 2008
Role of AMP-activated protein kinase in autophagy and proteasome functionRosa Viana, Carmen Aguado, Inmaculada Esteban, et al.
The Biochemical Journal|July 1, 2008
Human pancreatic beta-cell glucokinase: subcellular localization and glucose repression signalling function in the yeast cellAlberto Riera, Deifilia Ahuatzi, Pilar Herrero, et al.
Cells|April 30, 2021
TRIM32 and Malin in Neurological and Neuromuscular Rare DiseasesLorena Kumarasinghe, Lu Xiong, Maria Adelaida Garcia-Gimeno, et al.
FEBS Letters|November 3, 2012
Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathwayLuisa Garcia-Haro, Maria Adelaida Garcia-Gimeno, Dietbert Neumann, et al.
Pageof 11